Care este prețul pentru TMS Co., Ltd. (4891)

Prețul pentru TMS Co., Ltd. (4891) este $0.72420509

Care este capitalizarea de piață pentru TMS Co., Ltd. (4891)

Capitalizarea de piață pentru TMS Co., Ltd. (4891) este $33.00M

TMS Co., Ltd. (4891) Preț și Capitalizare de Piață

Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.

Prețul pentru 4891	Activul B	Capitalizarea de piață a B	Rezultate
$116,327 $33.00M	NVDA	$5.301T	+16,062,602.78%
$101,690 $33.00M	AAPL	$4.634T	+14,041,458.10%
$90,917.22 $33.00M	GOOG	$4.143T	+12,553,970.25%
$78,768.35 $33.00M	MSFT	$3.589T	+10,876,425.87%
$62,695.39 $33.00M	AMZN	$2.857T	+8,657,032.55%

Prețul pentru 4891

Activul B

Capitalizarea de piață a B

Rezultate

$116,327 $33.00M